BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1371945)

  • 1. The pharmacology of local anesthetics--a review of the literature.
    Young ER; MacKenzie TA
    J Can Dent Assoc; 1992 Jan; 58(1):34-42. PubMed ID: 1371945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacology of local anesthetics].
    Frankhuijzen AL
    Ned Tijdschr Tandheelkd; 1996 May; 103(5):170-3. PubMed ID: 11921929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local anesthetics from ester to isomer].
    Biscoping J; Bachmann-Mennenga MB
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 May; 35(5):285-92. PubMed ID: 10858837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a place for local anesthetics structurally different from classical amid or ester local anesthetics?
    Vegh V; Cizmarik J; Hahnenkamp K
    Curr Opin Anaesthesiol; 2006 Oct; 19(5):509-15. PubMed ID: 16960483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemistry and pharmacology of local anesthetics.
    Feyh LS
    CRNA; 1993 Nov; 4(4):161-9. PubMed ID: 8260915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The toxicity of local anesthetics: the place of ropivacaine and levobupivacaine.
    Zink W; Graf BM
    Curr Opin Anaesthesiol; 2008 Oct; 21(5):645-50. PubMed ID: 18784493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ropivacaine: a pharmacological review.
    Hansen TG
    Expert Rev Neurother; 2004 Sep; 4(5):781-91. PubMed ID: 15853505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine.
    Leone S; Di Cianni S; Casati A; Fanelli G
    Acta Biomed; 2008 Aug; 79(2):92-105. PubMed ID: 18788503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essentials of local anesthetic pharmacology.
    Becker DE; Reed KL
    Anesth Prog; 2006; 53(3):98-108; quiz 109-10. PubMed ID: 17175824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local anesthetics.
    Heavner JE
    Curr Opin Anaesthesiol; 2007 Aug; 20(4):336-42. PubMed ID: 17620842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of postoperative pain by continuous epidural infusion of analgesics.
    Shafer AL; Donnelly AJ
    Clin Pharm; 1991 Oct; 10(10):745-64. PubMed ID: 1742961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ropivacaine: an introduction to a new local anesthetic.
    Wicks TC
    CRNA; 1995 Aug; 6(3):129-34. PubMed ID: 7496365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidural catheter analgesia for the management of postoperative pain.
    Staren ED; Cullen ML
    Surg Gynecol Obstet; 1986 Apr; 162(4):389-404. PubMed ID: 3515598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local anesthetics in dental practice.
    Milam SB; Giovannitti JA
    Dent Clin North Am; 1984 Jul; 28(3):493-508. PubMed ID: 6589180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ropivacaine.
    Casati A; Santorsola R; Cerchierini E; Moizo E
    Minerva Anestesiol; 2001 Sep; 67(9 Suppl 1):15-9. PubMed ID: 11778088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ropivacaine produces sensory blockade in the lumbar sacral region more frequently than mepivacaine in lower thoracic epidural anesthesia.
    Suzuki M; Sugimoto K; Shimada Y
    J Anesth; 2004; 18(4):250-6. PubMed ID: 15549466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local anesthetics and their adjuncts.
    Mazoit JX
    Paediatr Anaesth; 2012 Jan; 22(1):31-8. PubMed ID: 21923815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiology and pharmacology of local anesthetic agents.
    Smith RB; Everett WG
    Int Ophthalmol Clin; 1973; 13(2):35-60. PubMed ID: 4202608
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interaction of local anesthetics with model ion channels].
    Isaeva GA; Dmitriev AV; Isaev PP
    Biofizika; 2002; 47(3):506-11. PubMed ID: 12068608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amide local anesthetics potently inhibit the human tandem pore domain background K+ channel TASK-2 (KCNK5).
    Kindler CH; Paul M; Zou H; Liu C; Winegar BD; Gray AT; Yost CS
    J Pharmacol Exp Ther; 2003 Jul; 306(1):84-92. PubMed ID: 12660311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.